Dana-Farber researcher is recipient of prestigious investigator award from National Cancer Institute

Pasi Jänne, MD, PhD, Director, Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute is a recipient of the prestigious Outstanding Investigator Award of the National Cancer Institute.

The National Cancer Institute (NCI) Outstanding Investigator Award (OIA) provides funding to investigators with outstanding records of productivity in cancer research to continue or embark upon new projects of unusual potential in cancer research over an extended period of seven years.  NCI developed the Award in 2014 to provide investigators with substantial time to break new ground or extend previous discoveries to advance biomedical, behavioral, or clinical cancer research.  

Award recipients are cancer researchers, nominated by their institutions, who have served as a principal investigator on an NCI grant for the last five years and have demonstrated outstanding cancer research productivity.  The OIA provides funding of up to $600,000 in direct costs per year for seven years.

“The NCI Outstanding Investigator Award addresses a problem that many cancer researchers experience: finding a balance between focusing on their science while ensuring that they will have funds to continue their research in the future,” said Dinah Singer, Ph.D., director of NCI’s Division of Cancer Biology.  “With seven years of uninterrupted funding, NCI is providing investigators the opportunity to fully develop exceptional and ambitious cancer research programs.”